From Banking to International Governance: Fostering Innovation in Stem Cell Research

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2011 Sep 10

PMID 21904557

Citations 11

Authors

Rosario Isasi

Bartha M Knoppers

Affiliations

Soon will be listed here.

Abstract

Stem cell banks are increasingly recognized as an essential resource of biological materials for both basic and translational stem cell research. By providing transnational access to quality controlled and ethically sourced stem cell lines, stem cell banks seek to foster international collaboration and innovation. However, given that national stem cell banks operate under different policy, regulatory and commercial frameworks, the transnational sharing of stem cell materials and data can be complicating. This paper will provide an overview of the most pressing challenges regarding the governance of stem cell banks, and the difficulties in designing regulatory and commercial frameworks that foster stem cell research. Moreover, the paper will shed light on the numerous international initiatives that have arisen to help harmonize and standardize stem cell banking and research processes to overcome such challenges.

Citing Articles

A double encryption protection algorithm for stem cell bank privacy data based on improved AES and chaotic encryption technology.

Wang L, Wei X, Zhang Y, Gao Y, Niu Q PLoS One. 2023; 18(10):e0293418.

PMID: 37878640 PMC: 10681628. DOI: 10.1371/journal.pone.0293418.

Considerations for an integrated population health databank in Africa: lessons from global best practices.

Igumbor J, Bosire E, Vicente-Crespo M, Igumbor E, Olalekan U, Chirwa T Wellcome Open Res. 2022; 6:214.

PMID: 35224211 PMC: 8844538. DOI: 10.12688/wellcomeopenres.17000.1.

Integrated Collection of Stem Cell Bank Data, a Data Portal for Standardized Stem Cell Information.

Chen Y, Sakurai K, Maeda S, Masui T, Okano H, Dewender J Stem Cell Reports. 2021; 16(4):997-1005.

PMID: 33740463 PMC: 8072026. DOI: 10.1016/j.stemcr.2021.02.014.

A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine.

Illes J, Sipp D, Kleiderman E, Benjaminy S, Isasi R, Lomax G NPJ Regen Med. 2018; 2:21.

PMID: 29302357 PMC: 5677945. DOI: 10.1038/s41536-017-0026-z.

The Clinical Applications of Endometrial Mesenchymal Stem Cells.

Zuo W, Xie B, Li C, Yan Y, Zhang Y, Liu W Biopreserv Biobank. 2017; 16(2):158-164.

PMID: 29265881 PMC: 5906727. DOI: 10.1089/bio.2017.0057.

References

Isasi R, Knoppers B . Beyond the permissibility of embryonic and stem cell research: substantive requirements and procedural safeguards. Hum Reprod. 2006; 21(10):2474-81. DOI: 10.1093/humrep/del235. View

Knoppers B, Isasi R . Stem cell banking: between traceability and identifiability. Genome Med. 2010; 2(10):73. PMC: 2988448. DOI: 10.1186/gm194. View

Lindvall O, Hyun I . Medical innovation versus stem cell tourism. Science. 2009; 324(5935):1664-5. DOI: 10.1126/science.1171749. View

Nakatsuji N . Banking human pluripotent stem cell lines for clinical application?. J Dent Res. 2010; 89(8):757-8. DOI: 10.1177/0022034510375288. View

Fox J . Human iPSC and ESC translation potential debated. Nat Biotechnol. 2011; 29(5):375-6. DOI: 10.1038/nbt0511-375a. View

Courtney A, De Sousa P, George C, Laurie G, Tait J . Balancing open source stem cell science with commercialization. Nat Biotechnol. 2011; 29(2):115-6. DOI: 10.1038/nbt.1773. View

Brevignon-Dodin L, Livesey F . Regulation of tissue-engineered products in the European Union: where are we heading?. Regen Med. 2007; 1(5):709-14. DOI: 10.2217/17460751.1.5.709. View

Lau D, Ogbogu U, Taylor B, Stafinski T, Menon D, Caulfield T . Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell. 2008; 3(6):591-4. DOI: 10.1016/j.stem.2008.11.001. View

Mathews D, Graff G, Saha K, Winickoff D . Access to stem cells and data: persons, property rights, and scientific progress. Science. 2011; 331(6018):725-7. DOI: 10.1126/science.1201382. View

10.

Check Hayden E . Stem cells: The growing pains of pluripotency. Nature. 2011; 473(7347):272-4. DOI: 10.1038/473272a. View

11.

Amariglio N, Hirshberg A, Scheithauer B, Cohen Y, Loewenthal R, Trakhtenbrot L . Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009; 6(2):e1000029. PMC: 2642879. DOI: 10.1371/journal.pmed.1000029. View

12.

Schneider C, Salmikangas P, Jilma B, Flamion B, Todorova L, Paphitou A . Challenges with advanced therapy medicinal products and how to meet them. Nat Rev Drug Discov. 2010; 9(3):195-201. DOI: 10.1038/nrd3052. View

13.

Crook J, Hei D, Stacey G . The International Stem Cell Banking Initiative (ISCBI): raising standards to bank on. In Vitro Cell Dev Biol Anim. 2010; 46(3-4):169-72. DOI: 10.1007/s11626-010-9301-7. View

14.

. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev Rep. 2009; 5(4):301-14. DOI: 10.1007/s12015-009-9085-x. View

15.

Isasi R . Policy interoperability in stem cell research: demystifying harmonization. Stem Cell Rev Rep. 2009; 5(2):108-15. DOI: 10.1007/s12015-009-9067-z. View

16.

Sugarman J, Siegel A . Research ethics. When embryonic stem cell lines fail to meet consent standards. Science. 2008; 322(5900):379. DOI: 10.1126/science.1164441. View

17.

Sipp D . Gold standards in the diamond age: the commodification of pluripotency. Cell Stem Cell. 2009; 5(4):360-3. DOI: 10.1016/j.stem.2009.09.005. View

18.

. WHO guiding principles on human cell, tissue and organ transplantation. Transplantation. 2010; 90(3):229-33. DOI: 10.1097/TP.0b013e3181ec29f0. View

19.

Lo B, Parham L, Alvarez-Buylla A, Cedars M, Conklin B, Fisher S . Cloning mice and men: prohibiting the use of iPS cells for human reproductive cloning. Cell Stem Cell. 2010; 6(1):16-20. PMC: 4035242. DOI: 10.1016/j.stem.2009.12.004. View

20.

Eisenstein M . Up for grabs. Nat Biotechnol. 2010; 28(6):544-6. DOI: 10.1038/nbt0610-544. View